PAHC Live signals | Maximize Profits with Getagraph.com

SELL 94375 min ago

@ $11.66

Issued: 14 Feb 2024 @ 10:17

Return: 14.07%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: -0.52 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States...

Stats
Today's Volume	124 758
Average Volume	141 909
Market Cap	538.70M
EPS	$0 ( 2024-02-07 )
Next earnings date	( $0.290 ) 2024-05-01
Last Dividend	$0.120 ( 2023-11-28 )
Next Dividend	$0 ( N/A )
P/E	35.95
ATR14	$0.0180 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-09	David Glenn	Buy	300 000	Restricted Stock Units
2024-02-09	David Glenn	Buy	0
2023-07-01	Weinstein Judith	Buy	0
2023-07-05	Miller Larry Lee	Buy	300 000	Restricted Stock Units
2023-02-06	Bernal Alejandro	Buy	0

INSIDER POWER
100.00
Last 94 transactions
Buy: 1 017 840 \| Sell: 862 050

Volume Correlation

Long: -0.05 (neutral)

Short: 0.32 (neutral)

Signal:(60.18) Neutral

Phibro Animal Health Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Phibro Animal Health Corp Correlation - Currency/Commodity

-0.61
( weak negative )

-0.33
( neutral )

0.00
( neutral )

-0.62
( weak negative )

-0.39
( neutral )

0.58
( weak )

Phibro Animal Health Corp Financials

Annual	2023
Revenue:	$977.89M
Gross Profit:	$298.24M (30.50 %)
EPS:	$0.810

Q4	2023
Revenue:	$255.05M
Gross Profit:	$76.67M (30.06 %)
EPS:	$0.280

Q3	2023
Revenue:	$245.70M
Gross Profit:	$75.60M (30.77 %)
EPS:	$0.250

Q2	2023
Revenue:	$244.65M
Gross Profit:	$77.39M (31.63 %)
EPS:	$0.180

Financial Reports:

No articles found.

Phibro Animal Health Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Phibro Animal Health Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.62 - good (76.22%) | Divividend Growth Potential Score: 5.50 - Stable (10.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.100	2014-08-29
Last Dividend	$0.120	2023-11-28
Next Dividend	$0	N/A
Payout Date	2023-12-20
Next Payout Date	N/A
# dividends	38	--
Total Paid Out	$4.22	--
Avg. Dividend % Per Year	1.85%	--
Score	4.59	--
Div. Sustainability Score	7.62
Div.Growth Potential Score	5.50
Div. Directional Score	6.56	--

Next Divdend (Est)
(2024-07-01)

$0.122 Estimate 39.46 %

Dividend Stability

0.79 Good

Dividend Score

4.59

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2014	$0.200	1.18%
2015	$0.400	1.30%
2016	$0.400	1.37%
2017	$0.400	1.35%
2018	$0.420	1.22%
2019	$0.480	1.50%
2020	$0.480	1.90%
2021	$0.480	2.44%
2022	$0.480	2.30%
2023	$0.480	3.51%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0151	1.500	9.70	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0152	1.200	9.49	10.00	[0 - 0.3]
returnOnEquityTTM	0.0539	1.500	-0.512	-0.768	[0.1 - 1]
payoutRatioTTM	1.312	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	3.12	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.295	0.800	7.09	5.67	[0.8 - 2.5]
cashRatioTTM	0.176	1.500	-0.135	-0.203	[0.2 - 2]
debtRatioTTM	0.527	-1.500	1.209	-1.813	[0 - 0.6]
interestCoverageTTM	2.55	1.000	-0.165	-0.165	[3 - 30]
operatingCashFlowPerShareTTM	1.833	2.00	9.39	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.914	2.00	9.54	10.00	[0 - 20]
debtEquityRatioTTM	1.895	-1.500	2.42	-3.63	[0 - 2.5]
grossProfitMarginTTM	0.304	1.000	8.27	8.27	[0.2 - 0.8]
operatingProfitMarginTTM	0.0498	1.000	-1.005	-1.005	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.145	1.000	-0.307	-0.307	[0.2 - 2]
assetTurnoverTTM	1.010	0.800	6.60	5.28	[0.5 - 2]
Total Score				7.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.17	1.000	6.45	0	[1 - 100]
returnOnEquityTTM	0.0539	2.50	-0.329	-0.768	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.914	2.00	9.70	10.00	[0 - 30]
dividendYielPercentageTTM	3.63	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.833	2.00	9.39	10.00	[0 - 30]
payoutRatioTTM	1.312	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	0.589	1.500	9.41	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0756	1.000	-0.610	0	[0.1 - 0.5]
Total Score				5.50

Phibro Animal Health Corp

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.